88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer • First patient dosed in Phase 3 LUTEON [1] trial evaluating TLX250-Tx in relapsed or recurrent clear cell renal cell carcinoma (ccRCC). • LUTEON is the first Phase 3 study of a CAIX [2] -targeted ... 2026-07-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Generative Bionics Introduces Gene.01, a Fully Functional Smart-Skin Humanoid Robot Platform Designed for Safe Human Collaboration Built in six months, Gene.01 senses touch, proximity, force, and temperature, and it is released with its open-sourced robot model that gives Physical AI developers a shared starting point to build industrial ... 2026-07-20T Biotechnology Computer Hardware Computer Software Computer/Electronics
Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs) DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures associated with DEEs, a diverse group of childhood-onset epilepsies 1 Broadest ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Medtrum Advances 300U Tubeless Patch Pump Toward German Launch Higher-capacity option expands the TouchCare Nano System and supports Medtrum's continued growth in Europe ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Announces Poster Presentation of ATG-022 and ATG-037 at ESMO 2026 SHANGHAI and HONG KONG , July 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Fostering new opportunities in the Greater Bay Area and Asia's Pharmaceutical Industry SHANGHAI , July 20, 2026 /PRNewswire/ -- Following the landmark success of CPHI & PMEC China in June 2026, which welcomed an unprecedented gathering of industry professionals and fostered pivotal ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Akeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC HONG KONG , July 20, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been dosed in a Phase II clinical study (AK146D1-201) ... 2026-07-20T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Fostering new opportunities in the Greater Bay Area and Asia's Pharmaceutical Industry SHANGHAI , July 20, 2026 /PRNewswire/ -- Following the landmark success of CPHI & PMEC China in June 2026, which welcomed an unprecedented gathering of industry professionals and fostered pivotal ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Neuronata-R retains conditional approval in South Korea South Korea's Ministry of Food and Drug Safety (MFDS) updates the stem cell therapy's approval in May 2026 — as the developer works to resume supply and build a U.S. research base ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an equity ... 2026-07-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved